Reporter sues FDA for documents related to Sarepta drug approval
A journalist has filed a federal lawsuit against the FDA seeking documents related to the agency ’s controversial approval last year of Exondys 51, a Duchenne muscular dystrophy treatment developed by Cambridge-based Sarepta Therapeutics.
Charles Seife, a journalist and professor at New York University, filed a complaint Thursday in Manhattan federal court challenging the FDA’s decision no t to disclose records that he requested under the Freedom of Information Act.
The documents relate to the…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Max Stendahl Source Type: news
More News: American Health | Health Management | Lawsuits | Legislation | Muscular Dystrophy | New York University | Reflex Sympathetic Dystrophy